Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease
NCT ID: NCT02086617
Last Updated: 2014-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2014-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Ethiology of AAA is known to be common with atherosclerotic arterial diseases, and on the basis of our previous studies (ClinicalTrials.gov ID CAD-AAA-02) the prevalence of AAA seems to be higher in CAD population than unselected male population. This leads to hypothesis that selective screening of these patients (for AAA) could be cost-efficient and life saving option for detecting AAAs before rupture.
Study will be carried out as a single-center prospective screening study. Patients will be selected for this study on basis of their ICD 10 diagnose codes in North Carelian patient information system. Inclusion criteria will be any kind of atherosclerotic heart disease (ICD10 codes I20-I25). Criteria for exclusion are malignant disease, already diagnosed or treated AAA and failure to give informed consent.
800 patient records that meet the inclusion criteria will be reviewed for eligibility. Invitations for screening will be sent for 600 patients with intention to have at least 400 patients screened. Screening will be done by verified sonographers in designated screening appointments.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms
NCT01850732
Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease
NCT01897623
Screening Cardiovascular Patients for Aortic Aneurysms
NCT01643317
Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound
NCT05617326
Ultra-sound for AAA Screening in Smoking Israeli Arab Men
NCT02306304
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
SCREENING
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ultrasound of aorta
ultrasound of aorta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound of aorta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient's denial to participate
* Malignant disease
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
North Karelia Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Carelia Central Hospital
Joensuu, Pohjois-Karjala, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAA-CAD-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.